Related Experiment Video
Updated: Oct 5, 2025
05:26
Establishing a Mouse Model of Thin Endometrium
Published on: November 1, 2024
1.0K
Cell-based therapy in thin endometrium and Asherman syndrome
Nastaran Gharibeh1,2, Leili Aghebati-Maleki3, Javad Madani2
1Student's Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran.
Stem Cell Research & Therapy
|January 29, 2022
Summary
Cell therapy offers a promising approach for endometrium regeneration, addressing limitations of traditional treatments for thin endometrium. Further research is needed to optimize this personalized and effective strategy.
Area of Science:
- Reproductive Medicine
- Regenerative Medicine
Background:
- Refractory thin endometrium, with or without Asherman syndrome, presents a significant clinical challenge.
- Existing therapies like tamoxifen, acupuncture, and hormonal treatments show inconsistent results in improving endometrial thickness.
Purpose of the Study:
- To review and discuss novel cell therapy approaches for endometrium regeneration.
- To explore the mechanisms and potential of cell-based treatments as an alternative to conventional methods.
Main Methods:
- Review of current literature on cell therapy for thin endometrium.
- Discussion of therapeutic agents including stem cells, platelet-rich plasma, and growth factors.
- Analysis of cell therapy's proposed mechanisms of action.
Main Results:
- Cell therapy mechanisms involve cytokine induction, growth factor production, and modulation of immune cells (NK, Th17, Th1, Treg, Th2).
- Cell therapy is characterized as personalized, dynamic, interactive, and specific.
- This approach holds potential as an effective strategy for endometrium regeneration.
Conclusions:
- Cell therapy represents a promising alternative for treating refractory thin endometrium.
- Further research is essential to refine procedures and ensure the safety of cell-based regenerative strategies.
